Solving the Antidepressant Efficacy Question: Effect Sizes in Major Depressive Disorder

被引:50
|
作者
Voehringer, Paul A. [1 ,2 ]
Ghaemi, S. Nassir [3 ]
机构
[1] Tufts Med Ctr, Dept Psychiat, Mood Disorders Program, Boston, MA 02111 USA
[2] Univ Chile, Fac Med, Hosp Clin, Santiago 7, Chile
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
antidepressants; effect size; meta-analysis; randomized clinical trials; STAR-ASTERISK-D; MAINTENANCE TREATMENT; BIPOLAR DISORDER; VENLAFAXINE; OUTCOMES; DISCONTINUATION; SEVERITY; PREVENT;
D O I
10.1016/j.clinthera.2011.11.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Numerous reviews and meta-analyses of the antidepressant literature in major depressive disorders (MDD), both acute and maintenance, have been published, some claiming that antidepressants are mostly ineffective and others that they are mostly effective, in either acute or maintenance treatment. Objective: The aims of this study were to review and critique the latest and most notable antidepressant MDD studies and to conduct our own reanalysis of the US Food and Drug Administration database studies specifically analyzed by Kirsch et al. Methods: We gathered effect estimates of each MDD study. In our reanalysis of the acute depression studies, we corrected analyses for a statistical floor effect so that relative (instead of absolute) effect size differences were calculated. We also critiqued a recent meta-analysis of the maintenance treatment literature. Results: Our reanalysis showed that antidepressant benefit is seen not only in severe depression but also in moderate depression and confirmed a lack of benefit for antidepressants over placebo in mild depression. Relative antidepressant versus placebo benefit increased linearly from 5% in mild depression to 12% in moderate depression to 16% in severe depression. The claim that antidepressants are completely ineffective, or even harmful, in maintenance treatment studies involves unawareness of the enriched design effect, which, in that analysis, was used to analyze placebo efficacy. The same problem exists for the standard interpretation of those studies, although they do not prove antidepressant efficacy either, since they are biased in favor of antidepressants. Conclusions: In sum, we conclude that antidepressants are effective in acute depressive episodes that are moderate to severe but are not effective in mild depression. Except for the mildest depressive episodes, correction for the statistical floor effect proves that antidepressants are effective acutely. These considerations only apply to acute depression, however. For maintenance, the long-term efficacy of antidepressants is unproven, but the data do not support the conclusion that they are harmful. (Clin Ther. 2011;33:B49-B61) (C) 2011 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:B49 / B61
页数:13
相关论文
共 50 条
  • [41] Major Depressive Disorder, Antidepressant Use, and Adiposity in Adolescents: a Longitudinal Study
    Calarge, Chadi
    Acion, Laura
    Coryell, William
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 404S - 404S
  • [42] Cognitive performance in antidepressant-free recurrent major depressive disorder
    Albert, Kimberly M.
    Potter, Guy G.
    McQuoid, Douglas R.
    Taylor, Warren D.
    DEPRESSION AND ANXIETY, 2018, 35 (08) : 694 - 699
  • [43] Restless Legs Syndrome: Associated with Major Depressive Disorder and Anxiety Disorder But Not with Antidepressant Use
    Yilbas, Baris
    Ozturk, Halil Ibrahim
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2022, 32 (02) : 125 - 133
  • [44] Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study
    Parikh, Sagar V.
    Aaronson, Scott T.
    Mathew, Sanjay J.
    Alva, Gustavo
    Debattista, Charles
    Kanes, Stephen
    Lasser, Robert
    Bullock, Amy
    Kotecha, Mona
    Jung, Jungah
    Forrestal, Fiona
    Jonas, Jeff
    Vera, Theresa
    Leclair, Bridgette
    Doherty, James
    NEUROPSYCHOPHARMACOLOGY, 2023, 49 (2) : 467 - 475
  • [45] Rumination in patients with major depressive disorder before and after antidepressant treatment
    Segerberg, Tina S. S.
    Ozenne, Brice
    Dam, Vibeke H.
    Kohler-Forsberg, Kristin
    Jorgensen, Martin B.
    Frokjaer, Vibe G.
    Knudsen, Gitte M.
    Stenbaek, Dea S.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 360 : 322 - 325
  • [46] Isokinetic muscle performance in major depressive disorder: Alterations by antidepressant therapy
    Bilici, M
    Cakirbay, H
    Koroglu, MA
    Guler, M
    Tosun, M
    Aydin, T
    Tan, U
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2001, 110 (1-2) : 9 - 23
  • [47] Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy
    Nelson, James Craig
    Thase, Michael E.
    Bellocchio, Elizabeth E.
    Rollin, Linda M.
    Eudicone, James M.
    McQuade, Robert D.
    Marcus, Ronald N.
    Berman, Robert M.
    Baker, Ross A.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (03) : 125 - 133
  • [48] Isokinetic muscle performance in major depressive disorder: Alterations by antidepressant therapy
    Bilici, M
    Koroglu, MA
    Cakirbay, H
    Guler, M
    Tosun, M
    Aydin, T
    Tan, U
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2001, 109 (3-4) : 149 - 164
  • [49] Neural Correlates of Antidepressant Treatment Response in Adolescents with Major Depressive Disorder
    Cullen, Kathryn R.
    Klimes-Dougan, Bonnie
    Dung Pham Vu
    Schreiner, Melinda Westlund
    Mueller, Bryon A.
    Eberly, Lynn E.
    Camchong, Jazmin
    Westervelt, Ana
    Lim, Kelvin O.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (08) : 705 - 712
  • [50] Antidepressant resistance in adolescents with major depressive disorder: A nationwide longitudinal study
    Chen, Li-Chi
    Chen, Yu-Hsiung
    Bai, Ya-Mei
    Chen, Tzeng-Ji
    Chen, Mu-Hong
    Su, Tung-Ping
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 262 : 293 - 297